Delivery Order SPE2DB22D2006-SPE2DB25FW2LS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1.74K to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Atropine 8 mg/20 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This delivery order falls...
- The Defense Logistics Agency awarded a $1,654.50 delivery order to AmerisourceBergen Drug Corp for Atropine 8 mg/20 mL vials on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,362.26 to AmerisourceBergen Drug Corp for the supply of Atropine 8 mg/20 mL vials on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designations and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,074.04 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atropine 1 mg/mL in vial form, with an ultimate completion date of September 18, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.30 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,891.40 delivery order to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials under a firm fixed price contract. This non-set-aside award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atropine is a critical medication used in military and federal healthcare settings for emergency medical treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,134.87 to AmerisourceBergen Drug Corp for Atropine 1 mg/mL vials, with an ultimate completion date of August 27, 2025. This is a firm fixed-price, non-set-aside contract executed on August 26, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical supplier to the federal...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2LSDelivery Order
The Defense Logistics Agency awarded a $1,440.29 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Atropine 8 mg/20 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supports defense health programs including the Defense Health Agency and U.S. Coast Guard through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/14/25 |